Calculate Your Salary Ranking
Home > Koronis Pharmaceuticals Salary

Koronis Pharmaceuticals Salary
  • 40
  • 30
  • 77

Koronis Pharmaceuticals average salary is $44,452, median salary is $45,319 with a salary range from $34,080 to $53,090.
Koronis Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Koronis Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 2 Koronis Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Research Associate/microbiologist 34,080-37,548 Redmond, WA, 98052 2010 Koronis Pharmaceuticals Research Associate/microbiologist Salaries (2)
Koronis Pharmaceuticals Redmond, WA Salaries
Staff Scientist 53,090-53,090 Redmond, WA, 98052 2010 Koronis Pharmaceuticals Staff Scientist Salaries (2)
Koronis Pharmaceuticals Redmond, WA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Koronis Pharmaceuticals Salaries (February 28, 2017)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Koronis Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Koronis Pharmaceuticals Information
  • Koronis Pharmaceuticals
  • Industry: BioTech/Drugs
  • City: Seattle, WA
  • Koronis Pharmaceuticals is pioneering the development of a new class of anti-viral therapeutics based on a novel mechanism ¨C Viral Decay Acceleration? (VDA).Unlike other therapeutics that are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation.